Serum total IgE is used in practice to verify that a patient with severe allergic asthma could be a candidate for omalizumab therapy and blood eosinophils count (usually ≥300 cells/μL) to prescribe biological agents such as anti-IL5 antibody in the eosinophilic refractory severe asthma. This evidence concerns the gene IGHE and allergic asthma.